Myalgic Encephalomyelitis: Clinical Trials

4 trials for Myalgic Encephalomyelitis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 recruiting, 1 unknown. 4 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 14Completed 2, Recruiting 1, Unknown 1
Phase 22Completed 1, Recruiting 1

Follow Myalgic Encephalomyelitis: new trials by email Literature Review of Myalgic Encephalomyelitis trials Research Report on Myalgic Encephalomyelitis

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Lumbrokinase for Adults With Long Covid, Post-treatment Lyme Disease Syndrome, and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
Lumbrokinase - Long Covid, Post-treatment Lyme Disease Syndrome
Phase 1 / Phase 2RecruitingIcahn School of Medicine at Mount Sinai1202024-10-092026-03-13
Effect of Stellate Ganglion Block on ME/CFS
Bupivacaine Injection - Encephalomyelitis, Myalgic, Chronic Fatigue Syndrome
Phase 1CompletedNeuroversion, Inc.102023-03-152024-12-06
Clinical Trial to Investigate CT38 in the Treatment of Myalgic Encephalomyelitis / Chronic Fatigue Syndrome
CT38 - Myalgic Encephalomyelitis, Chronic Fatigue Syndrome
Phase 1 / Phase 2CompletedLUCINDA BATEMAN, MD172018-07-232020-05-12
Reducing Orthostatic Intolerance With Oral Rehydration in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients
Normal Saline, Oral Rehydration Solution - Chronic Fatigue Syndrome, Myalgic Encephalomyelitis
Phase 1UnknownNew York Medical College452016-02-012021-06-10

Narrower conditions

Fatigue Syndrome, Chronic (4)  ·  Orthostatic Intolerance (2)  ·  Lyme Disease (1)  ·  Mental Fatigue (1)  ·  Osteoarthritis (1)  ·  Post-Acute COVID-19 Syndrome (1)  ·  Post-Lyme Disease Syndrome (1)  ·  Postural Orthostatic Tachycardia Syndrome (1)  ·  Syncope, Vasovagal (1)

Broader conditions

Chronic Disease (4)  ·  Disease Attributes (4)  ·  Encephalomyelitis (4)  ·  Muscular Diseases (4)  ·  Musculoskeletal Diseases (4)  ·  Nervous System Diseases (4)  ·  Neuroinflammatory Diseases (4)  ·  Neuromuscular Diseases (4)  ·  Pathologic Processes (4)  ·  Pathological Conditions, Signs and Symptoms (4)  ·  Autonomic Nervous System Diseases (2)  ·  Neurologic Manifestations (2)  ·  Primary Dysautonomias (2)  ·  Signs and Symptoms (2)  ·  Arthritis (1)

Interventions

Bupivacaine (1)  ·  ORALIT (1)  ·  Saline Solution (1)  ·  World Health Organization oral rehydration solution (1)  ·  lumbrokinase (1)

Sponsors

Icahn School of Medicine at Mount Sinai (1)  ·  LUCINDA BATEMAN, MD (1)  ·  Neuroversion, Inc. (1)  ·  New York Medical College (1)

Countries

United States (4)

Top investigators

David Putrino, PhD, PT (1)  ·  Deborah L Duricka, PhD (1)  ·  Lucinda Bateman, MD (1)  ·  Marvin S. Medow, Ph.D. (1)  ·  Suzanne D Vernon, PhD (1)

Results publications

PMID 34539356

NIH funding

R21NS094644 (1)